Palisade Bio Announces Enrollment of First Patient in Newsoara Phase 3 Clinical Trial Evaluating LB1148
Enrollment triggers milestone payment Carlsbad, CA and Shanghai, China, April 05, 2023 (GLOBE NEWSWIRE) — Palisade…
Enrollment triggers milestone payment Carlsbad, CA and Shanghai, China, April 05, 2023 (GLOBE NEWSWIRE) — Palisade…
VANCOUVER, Washington, April 05, 2023 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the…
Glen Rock, N.J., April 05, 2023 (GLOBE NEWSWIRE) — RespireRx Pharmaceuticals Inc. (OTC Markets: RSPI)…
SOUTH SAN FRANCISCO, Calif., April 05, 2023 (GLOBE NEWSWIRE) — Surrozen, Inc. (“Surrozen” or the…
Launches Turn-Key Contract Development and Manufacturing Plus Distribution (CDMO+D) Solution for Industry Leading Hemp/Cannabis Brands…
Recent upgrades lead to testing results that show Verizon customers have the best network experience…
Recent upgrades lead to testing results that show Verizon customers have the best network experience…
The ‘Technology Tools for Today’ Inside Survey recognized Paperclip’s SAFE®, Internet eXpress and VCF solutions…
NEW YORK, NY, Apr 5, 2023 – (ACN Newswire) – FBS has concluded its Ultimate…
DURHAM, N.C., April 05, 2023 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the…
– Investor call to be held at 9:00 a.m. ET on April 18, 2023 –…
– Investor call to be held at 9:00 a.m. ET on April 18, 2023 –…
MONTREAL, April 05, 2023 (GLOBE NEWSWIRE) — Sunshine Biopharma Inc. (NASDAQ: “SBFM”), a pharmaceutical company…
MONTREAL, April 05, 2023 (GLOBE NEWSWIRE) — Sunshine Biopharma Inc. (NASDAQ: “SBFM”), a pharmaceutical company…
Eight additional national and regional health plans are now covering ZORYVE for plaque psoriasis ZORYVE…
Eight additional national and regional health plans are now covering ZORYVE for plaque psoriasis ZORYVE…
Rajavelu to continue supporting Fulcrum in a consulting capacity CAMBRIDGE, Mass., April 05, 2023 (GLOBE NEWSWIRE)…
Rajavelu to continue supporting Fulcrum in a consulting capacity CAMBRIDGE, Mass., April 05, 2023 (GLOBE NEWSWIRE)…
Significant reduction of toxic protein aggregate, Poly(GP) Significant increase in biomarker of target engagement, sGPNMB…
Significant reduction of toxic protein aggregate, Poly(GP) Significant increase in biomarker of target engagement, sGPNMB…